NUTX Nutex Health Inc. Loading... : Investor Sentiment and Bull/Bear Views
Loading chart...
Top Calls
No data yet
Price change since each call, adjusted for long/short direction. Results calculated:
Feed
06:12
Jan 26
Jan 26
DCF shows NUTX 158% upside, regulatory risk priced in
The author's DCF model, using base-case revenue growth from 80% in year 1 tapering to 4% by year 10 and EBIT margins rising to 27.5%, yields a fair value of $403 per share, implying 158% upside with a 61.3% margin of safety. The core business driver is arbitrage revenue from out-of-network billing, which the author says has won 85% of cases against insurers like UNH and represents 75% of revenue. The main stated risk is regulatory: a possible restriction of IRP arbitrage opportunities, which the author claims the stock is already heavily discounting. The author notes worst-case models assuming a 30% revenue drop from CMS arbitrage limits still return fair values above the current price.
HIGH
About NUTX Investor Commentary
Across the available history and selected sources, Buzzberg tracks NUTX (Nutex Health Inc.) across 1 sources: 1 bullish vs 0 bearish calls from 1 authors. Historical directional balance: 100% = 100 × (bullish − bearish) / all deduplicated idea records, including other directions. This is neither a probability of a price rise nor the share of bullish authors. 1 total trade idea tracked. Latest voices: u/The_wsj.